Description
| Product Name | CAT.No | Size |
| Infectious Mononucleosis | LXIM00020 | 20T |
Product Description
The Biorex Diagnostics Infectious Mononucleosis (IM) Test is a rapid slide agglutination assay designed for the qualitative detection of heterophile antibodies associated with Epstein-Barr virus (EBV) infection in human serum. This ready-to-use, easy-to-perform test provides fast, reliable, and clinically relevant results, making it ideal for clinical laboratories, hospitals, diagnostic centres, and point-of-care settings. The assay enables timely diagnosis and monitoring of Infectious Mononucleosis, supporting effective patient management and informed clinical decision-making.
Key Features
- Rapid and reliable – provides clear agglutination results within minutes for fast decision-making
- High sensitivity and specificity – accurately detects heterophile antibodies associated with EBV infection
- Ready-to-use format – eliminates reagent preparation, reducing handling errors and ensuring consistent performance
- Simple procedure – minimal training required, no specialised equipment needed
- Versatile application – suitable for both laboratory and point-of-care testing
- Cost-effective – ideal for routine screening, outbreak monitoring, and large-scale testing programs
Benefits
Routine use of the Biorex IM Test allows laboratories and clinics to quickly identify individuals with Infectious Mononucleosis, supporting early intervention and monitoring of disease progression. The slide agglutination technique is straightforward and user-friendly, reducing the risk of operator error and simplifying workflow. High sensitivity and specificity ensure that positive and negative results are reliably distinguished, providing clinicians with confidence in their diagnostic decisions. The ready-to-use formulation saves time, streamlines laboratory processes, and reduces the potential for preparation errors, making it suitable for high-throughput testing environments as well as smaller clinics or point-of-care settings.
By incorporating the Biorex IM Test into routine diagnostic protocols, healthcare providers can improve patient care through faster, more accurate detection of EBV infection. Its rapid, reliable, and clinically validated performance supports laboratory efficiency, maintains high standards of diagnostic quality, and enhances patient safety. This test is an essential tool for immunology laboratories, hospital diagnostic units, and clinics focused on accurate detection and monitoring of Infectious Mononucleosis.
Contact Us for more information.